Drug application
SUMATRIPTAN SUCCINATE (SUMATRIPTAN SUCCINATE)
Drugs@FDA ANDA 078318 · TEVA PARENTERAL
Key facts
| Drug name | SUMATRIPTAN SUCCINATE |
|---|---|
| Active ingredients | SUMATRIPTAN SUCCINATE |
| Application type | ANDA |
| Application number | 078318 |
| Company | TEVA PARENTERAL |
| Dosage forms | SOLUTION, SUBCUTANEOUS |
| Strength | EQ 4MG BASE/0.5ML (EQ 8MG BASE/ML) |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Jul 29, 2008 |
At a glance
- 1–9 Submissions
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
- No FDA letters on file
- No FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: